{"TopicDetails": {"type": 0, "ccm2Id": 44188100, "cftId": 0, "identifier": "EU4H-2021-PJ-01", "title": "Action grants on collection tasks in relation to updating the European Cancer Information System to monitor and assess cancer screening programmes", "publicationDateLong": 1624579200000, "callIdentifier": "EU4H-2021-PJ", "callTitle": "Project grants", "callccm2Id": 44188116, "allowPartnerSearch": true, "workProgrammepart": {"id": 5874, "ccm_id": 44188220, "wp_part": "EU4H-2021", "wp_year": "EU4H-2021", "wp_title": "EU4H-2021", "wp_website": "https://ec.europa.eu/health/", "wp_document": "https://ec.europa.eu/health/funding/eu4health_en"}, "frameworkProgramme": {"id": 43332642, "abbreviation": "EU4H", "description": "EU4 Health Programme (EU4H)"}, "programmeDivision": [{"id": 43332657, "abbreviation": "Health", "description": "Improving and fostering health in the Union to reduce the burden of communicable and non-communicable diseases"}, {"id": 43332653, "abbreviation": "EU4H-1", "description": "EU4H-1"}], "topicMGAs": [], "tags": ["monitoring", "screening", "indicator", "European Cancer Information System", "ECIS", "data", "survival", "workshop", "cancer"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "EU4H-PJG EU4H Project Grants", "typeOfMGA": [{"id": 43326018, "abbreviation": "EU4H-AG", "description": "EU4H Action Grant Budget-Based"}]}], "plannedOpeningDate": "29 July 2021", "submissionProcedure": {"id": 31094504, "abbreviation": "single-stage", "description": "single-stage"}, "deadlineDates": ["15 September 2021"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3359496": [{"action": "EU4H-2021-PJ-04 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "29 July 2021", "deadlineModel": "single-stage", "deadlineDates": ["15 September 2021"], "budgetYearMap": {"2021": 5000000}, "budgetTopicActionMap": {}}], "3359498": [{"action": "EU4H-2021-PJ-02 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "29 July 2021", "deadlineModel": "single-stage", "deadlineDates": ["15 September 2021"], "budgetYearMap": {"2021": 5000000}, "budgetTopicActionMap": {}}], "3359500": [{"action": "EU4H-2021-PJ-01 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "29 July 2021", "deadlineModel": "single-stage", "deadlineDates": ["15 September 2021"], "budgetYearMap": {"2021": 2000000}, "budgetTopicActionMap": {}}], "3359502": [{"action": "EU4H-2021-PJ-05 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "29 July 2021", "deadlineModel": "single-stage", "deadlineDates": ["15 September 2021"], "budgetYearMap": {"2021": 3500000}, "budgetTopicActionMap": {}}], "3359504": [{"action": "EU4H-2021-PJ-03 - EU4H-PJG EU4H Project Grants", "plannedOpeningDate": "29 July 2021", "deadlineModel": "single-stage", "deadlineDates": ["15 September 2021"], "budgetYearMap": {"2021": 3500000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2021"]}, "description": "<SPAN class=\"topicdescriptionkind\">Objective</SPAN>:<p><strong>Background and policy context</strong><br>The European Cancer Information System (ECIS) managed by the Joint Research Centre provides the latest information on indicators that quantify cancer burden across Europe. It permits the exploration of geographical patterns and temporal trends of incidence, mortality and survival data across Europe for the major cancer entities. The survival rate for cervical, breast and colorectal cancer is a key indicator of how effective healthcare systems are in cancer care, reflecting both efficiency in early detection and the effectiveness of treatment. There is a need to further develop the ECIS to enable the monitoring and assessment of cancer screening programmes, which will require the collection of the relevant data from those entities in the Member States responsible for cancer screening.<br>This action supports the implementation of a Europe\u2019s Beating Cancer Plan flagship initiative and links with the European Health Data Space and implements the EU4Health Programme\u2019s general objective of improving and fostering health in the Union (Article 3, point (a)) through the specific objectives defined in Article 4, points (a), (f) and (i) of Regulation (EU) 2021/522.</p><p><strong>Objectives pursued</strong><br>This action supports the linking of data provided by the cancer screening programmes into ECIS with a view to allowing the permanent monitoring of the screening programmes, including the performance indicators.<br>The action will consist in the collection of data from entities in the Member States that are responsible for collecting data on cancer screening, in order to provide this data to ECIS, and develop a piloting of the new ECIS functionality as well as a new separate section to ensure a permanent collection and monitoring of the coverage and performance indicators of population-based cancer screening across the Union.</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><strong>Description of the activities to be funded under this topic</strong></p><p>1. Preparatory work through meetings (5) and workshops (5) to create a platform in which data and indicators on population-based cancer screening programmes are collected, collated and further assessed under the European Cancer Information System.<br>2. Actions to support the first piloting of the platform developed under point 1, including collection of available datasets related to breast, colorectal and cervical cancer screening programmes.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p><strong>Expected results and impact</strong></p><p>The expected result is the collection of the relevant cancer screening data from the Member States.<br>This action aims at improving the monitoring of the implementation of cancer screening programmes across the Union, and will have an impact on the implementation of such programmes by providing the Member States with evidence-based information to strengthen their programmes.</p><p><strong>Specific mandatory deliverables and/or milestones</strong></p><p>None</p><p><strong>Specific indicators for reporting purposes</strong></p><p>The applicants will include the following specific action-level indicators and related reporting activities in their proposals:<br>- number of data providers (thematic coverage);<br>- number of Member States participating;<br>- number of data/themes collected and made available on cancer screening;<br>- number of performance and outcome indicators made available on cancer screening;<br>- number of data sets tested through the piloting phase;<br>- number of access/downloads of the data.<br>The applicants are required to include in their proposals additional specific action-level indicators which will be agreed with the HaDEA during the grant agreement preparation.</p>\n", "conditions": "<p><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Conditions<br />\r\n<br type=\"_moz\" />\r\n</span></b></p>\r\n<p><b><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:&#10;text1;mso-themetint:191;mso-ansi-language:EN-US\">1.&nbsp;</span></b><b><span lang=\"EN-US\">Admissibility conditions: </span></b><span lang=\"EN-US\">described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">&nbsp;</a></p>\n<p><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\">&nbsp;described in section 5 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"EN-US\">2. Eligible countries:&nbsp;</span></b><span lang=\"EN-US\">described in section 6 of of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\">&nbsp;described in section 6 of the <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b>4. Financial and operational capacity and exclusion:&nbsp;</b>described in&nbsp;<span lang=\"EN-US\">section 7 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></p>\n<p><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></p>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Award criteria, scoring and thresholds:</span></b><span lang=\"EN-US\">&nbsp;described in section 9 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Submission and evaluation processes</span></b><b><span lang=\"EN-US\">:</span></b><span lang=\"EN-US\">&nbsp;described&nbsp;<span style=\"color: rgb(64, 64, 64);\">section 8 of the call document and the</span>&nbsp;</span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span lang=\"EN-US\">Online Manual</span></a></li>\r\n</ul>\n<ul>\r\n    <li><b><span lang=\"EN-US\">Indicative timeline for evaluation and grant agreement:&nbsp;</span></b><span lang=\"EN-US\">described in section 4 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></li>\r\n</ul>\n<p><b><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">6</span></b><b><span lang=\"EN-US\">. Legal and financial set-up of the grants:&nbsp;</span></b><span lang=\"EN-US\">described&nbsp;<span style=\"color: rgb(64, 64, 64);\">in section 10 of the <a href=\"http://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">call document</a></span></span></p>\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><b><span lang=\"EN-US\" style=\"font-size: 12pt; line-height: 18.4px; color: rgb(64, 64, 64);\">Documents<br />\r\n<br />\r\n<o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\"><b><span lang=\"EN-US\">Call documents:</span></b></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\">Text of the EU4HEALTH Call document:&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/wp-call/2021/call-fiche_eu4h-2021-pj_en.pdf\" target=\"_blank\">Call document </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;mso-ansi-language:&#10;EN-US\">Standard application form&nbsp;&nbsp;</span><span style=\"color:#404040;&#10;mso-themecolor:text1;mso-themetint:191\">&mdash;</span><i style=\"mso-bidi-font-style:&#10;normal\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\">&nbsp;<a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/af_eu4h_en.pdf\" target=\"_blank\">EU4HEALTH Standard application</a></span></i></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color:#404040;mso-themecolor:text1;mso-themetint:191;&#10;mso-ansi-language:EN-US\">Detailed budget table -&nbsp; <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/temp-form/af/detailed-budget-table_eu4h_en.xlsm\" target=\"_blank\">EU4HEALTH DETAILED BUDGET</a></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:4.0pt;line-height:normal;tab-stops:&#10;191.4pt\"><span style=\"color:#404040;mso-themecolor:text1;mso-themetint:&#10;191;mso-fareast-language:EN-GB;mso-no-proof:yes\">EU4Health programme- <a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/eu4h/agr-contr/mga_eu4h_en.pdf\" target=\"_blank\">EU4Health&nbsp; MGA v1.0 </a><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:4.0pt;line-height:normal;tab-stops:&#10;191.4pt\">&nbsp;</p>\n<p><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">EU4Health -</span><span lang=\"EN-US\" style=\"font-size: 10pt; line-height: 15.3333px; font-family: &quot;Segoe UI&quot;, sans-serif; color: rgb(64, 64, 64);\">&nbsp;</span><span class=\"MsoHyperlink\"><span style=\"color: rgb(64, 64, 64);\">&nbsp;<a href=\"https://ec.europa.eu/health/sites/default/files/funding/docs/wp2021_annex_en.pdf\" target=\"_blank\">2021 Annual Work Programme</a></span></span></p>\r\n<p><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">EU4Health Regulation:&nbsp;<a href=\"http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32021R0522&amp;qid=1619441027093\" target=\"_blank\">EU4Health Regulation 2021/522</a></span><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><br />\r\n</span>EU Financial Regulation:&nbsp;<a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span lang=\"EN-US\">EU Financial Regulation 2018/1046</span></a></p>", "supportInfo": "<p><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">For help related to this</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><b style=\"font-family: Arial, sans-serif; font-size: 9pt;\">call</b><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">, please contact:</span><span style=\"font-family: Arial, sans-serif; font-size: 9pt;\">&nbsp;</span><strong>HADEA-HP-CALLS@ec.europa.eu&nbsp;&nbsp;</strong></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;grantAndTendertype=1;categories=p_submission_eval;programme=null;actions=;keyword=;period=null\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Funding &amp; Tenders Portal FAQ</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Submission of proposals.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">IT Helpdesk</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"line-height: normal;\"><a href=\"https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual\"><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">Online Manual</span></a><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; Step-by-step online guide through the Portal processes from proposal preparation and submission to reporting on your on-going project. Valid for all 2021-2027 programmes.</span></p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"staticAdditionalInfo": "<p>On 24 March 2021, the EU4Health Regulation was adopted as part of the EU Multiannual Financial Framework for the 2021-2027 period. The EU4Health Regulation established \u2018the EU4Health Programme\u2019. This marks an important step towards making available instruments and solutions to support Member States in building stronger, more resilient and accessible health systems.</p><p>The EU4Health Programme represents an unprecedented level of financial commitment for the EU in health in comparison with previous health programmes. The Programme is EU\u2019s response to the current public health emergency that will make a significant contribution to the post-COVID-19 recovery aiming to:<br>- improve public health in the Union through disease prevention and health promotion, as well as international health initiatives and cooperation;<br>- protect people from serious cross-border health threats through prevention, preparedness and response to cross-border health threats; complementing national stockpiling of essential crisis-relevant products; and establishing a reserve of medical, healthcare and support staff;<br>- improve access to medicinal products, medical devices and crisis-relevant products by encouraging sustainable production and supply chains and innovation in the Union and efficient use of medicinal products;<br>- strengthen the national health systems through improved health data use and re-use, development of digital tools and services, digital transformation of healthcare; enhancing access to healthcare; developing and implementing EU health legislation and evidence-based decision making; and integrated work among Member States\u2019 health systems.</p><p>Cancer is the second leading cause of mortality in the Member States after cardiovascular disease. The prevention and control of cancer would benefit the majority of citizens since it shares common risk factors with other non-communicable diseases. Europe\u2019s Beating Cancer Plan, which is a key pillar of a stronger European Health Union, tackles the entire cancer disease pathway by means of flagship initiatives, such as launching a Cancer Inequalities Registry, and supporting actions, such as establishing an EU Network of Youth Cancer Survivors. The EU4Health programme will provide the financial support to implement these initiatives that are important to mitigate the impact of the COVID-19 pandemic on cancer control and care.</p><p>Grants shall involve co-financing. Grants paid by the Union shall not exceed 60 % of eligible costs for an action relating to an objective of the Programme. In cases of exceptional utility, the contribution by the Union may be up to 80 % of eligible costs.</p>\n", "latestInfos": [{"approvalDate": "Jul 29, 2021 11:52:53 AM", "lastChangeDate": "Jul 29, 2021 11:52:53 AM", "content": "The submission session is now available for: EU4H-2021-PJ-03(EU4H-PJG), EU4H-2021-PJ-01(EU4H-PJG), EU4H-2021-PJ-04(EU4H-PJG), EU4H-2021-PJ-02(EU4H-PJG), EU4H-2021-PJ-05(EU4H-PJG)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}